Lumos Pharma Inc. (LUMO)
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 9:00 PM
Lumos Pharma Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 2.05M | 1.52M | 230K | 168K | 936K | 1.21M | 390K | 3.53M | 36.14M | 165.95M | 1.09M | 1.69M | 1.87M | 2.08M | 934K | 633K |
| Cost of Revenue | n/a | 49K | n/a | n/a | 37K | -11.27M | 1.41M | n/a | -32.36M | -6.64M | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 2.05M | 1.47M | 230K | 168K | 899K | 12.47M | -1.02M | 3.53M | 68.5M | 172.59M | 1.09M | 1.69M | 1.87M | 2.08M | 934K | 633K |
| Operating Income | -36.61M | -32.04M | -31.35M | -26.3M | -45.13M | -62.44M | -72.88M | -90.76M | -33.6M | 117.57M | -31.14M | -23.26M | -18.06M | -16.66M | -9.82M | -9.41M |
| Interest Income | 1.87M | 874K | 12K | 200K | 2.23M | 2.03M | 616K | 237K | 78K | 86K | 12K | 14K | 11K | 75K | 132K | 213K |
| Pretax Income | -34.06M | -31.07M | -31.07M | -19.64M | -42.98M | -60.56M | -72.51M | -90.51M | -33.64M | 117.63M | -31.05M | -23.32M | -18.09M | -16.59M | -9.8M | -9.37M |
| Net Income | -34.03M | -31.06M | -30.43M | -5.66M | -42.99M | -53.59M | -71.95M | -85.16M | -40.38M | 102.86M | -31.18M | -23.32M | -18.09M | -16.21M | -9.44M | -9.16M |
| Selling & General & Admin | 16.57M | 15.71M | 15.33M | 17.27M | 23.86M | 29.22M | 31.73M | 33.23M | 30.69M | 19.33M | 9.52M | 7.11M | 5.68M | 6.07M | 5.19M | 4.6M |
| Research & Development | 22.1M | 17.86M | 16.25M | 9.21M | 22.2M | 45.69M | 69.87M | 93.3M | 71.41M | 35.69M | 22.71M | 17.84M | 14.26M | 12.67M | 5.56M | 5.45M |
| Other Expenses | n/a | 91K | 269K | 6.47M | -19K | -102K | 371K | 247K | -41K | 60K | 91K | -62K | n/a | n/a | n/a | n/a |
| Operating Expenses | 38.66M | 33.56M | 31.58M | 26.47M | 46.07M | 63.64M | 73.27M | 94.28M | 69.75M | 48.38M | 31.14M | 23.26M | 19.93M | 18.74M | 10.75M | 10.05M |
| Interest Expense | n/a | 874K | n/a | n/a | 50K | 52K | 119K | 22K | 105K | 26K | 33K | 38K | 42K | 47K | 9K | 2K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 38.66M | 33.56M | 31.58M | 26.47M | 46.07M | 63.64M | 73.27M | 94.28M | 69.75M | 48.38M | 31.14M | 23.26M | 19.93M | 18.74M | 10.75M | 10.05M |
| Income Tax | -29K | -13K | -636K | -13.97M | 12K | -6.97M | -559K | -5.36M | 6.74M | 14.78M | 130K | -788K | 41K | -448K | -375K | -253K |
| Shares Outstanding (Basic) | 8.15M | 8.37M | 8.33M | 6.78M | 144.71K | 4.13M | 3.48M | 3.22M | 3.18M | 3.09M | 2.81M | 2.31M | 673.84K | 1.6M | 1.6M | 1.6M |
| Shares Outstanding (Diluted) | 8.15M | 8.37M | 8.33M | 6.78M | 144.71K | 4.13M | 3.48M | 3.22M | 3.18M | 3.45M | 2.81M | 2.31M | 673.84K | 1.6M | 1.6M | 1.6M |
| EPS (Basic) | -4.18 | -3.71 | -3.65 | -0.84 | -297.07 | -12.97 | -20.69 | -26.45 | -12.71 | 31.05 | -11.1 | -10.1 | -26.84 | -10.15 | -5.91 | -5.74 |
| EPS (Diluted) | -4.18 | -3.71 | -3.65 | -0.84 | -297.07 | -12.97 | -20.69 | -26.45 | -12.71 | 27.81 | -11.1 | -10.1 | -26.84 | -10.15 | -5.91 | -5.74 |
| EBITDA | -36.57M | -31.99M | -31.13M | -25.72M | -45.13M | -59.37M | -70.98M | -88.41M | -31.95M | 118.76M | -30.13M | -22.5M | -17.52M | -16.08M | -9.89M | -9.12M |
| Depreciation & Amortization | 44K | 49K | 273K | 584K | 37K | 1.15M | 1.41M | 2.08M | 1.59M | 1.1M | 891K | 788K | 687K | 655K | 303K | 294K |